000			01606 a2200445 4500
005			20250515031734.0
264		0	_c20061207
008			200612s 0 0 eng d
022			_a0033-3158
024	7		_a10.1007/s00213-006-0430-3 _2doi
040			_aNLM _beng _cNLM
100	1		_aRode, Frederik
245	0	0	_aVenlafaxine compromises the antinociceptive actions of gabapentin in rat models of neuropathic and persistent pain. _h[electronic resource]
260			_bPsychopharmacology _cAug 2006
300			_a364-75 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAmines _xadministration & dosage
650	0	4	_aAnalgesics _xtherapeutic use
650	0	4	_aAnimals
650	0	4	_aCyclohexanecarboxylic Acids _xadministration & dosage
650	0	4	_aCyclohexanols _xadministration & dosage
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Therapy, Combination
650	0	4	_aGabapentin
650	0	4	_aHyperalgesia _xdrug therapy
650	0	4	_aKidney _xdrug effects
650	0	4	_aMale
650	0	4	_aNeuralgia _xdrug therapy
650	0	4	_aPain _xdrug therapy
650	0	4	_aPain Measurement
650	0	4	_aRats
650	0	4	_aRats, Inbred BN
650	0	4	_aVenlafaxine Hydrochloride
650	0	4	_agamma-Aminobutyric Acid _xadministration & dosage
700	1		_aBroløs, Tine
700	1		_aBlackburn-Munro, Gordon
700	1		_aBjerrum, Ole J
773	0		_tPsychopharmacology _gvol. 187 _gno. 3 _gp. 364-75
856	4	0	_uhttps://doi.org/10.1007/s00213-006-0430-3 _zAvailable from publisher's website
999			_c16377899 _d16377899